相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins
L. Wagner et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology
Anneleen Mortier et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
The efficacy and safety of DPP4 inhibitors compared to sulfonylureas as add-on therapy to metformin in patients with Type 2 diabetes: A systematic review and meta-analysis
Basem M. Mishriky et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2015)
High expression of CD26 accurately identifies human bacteria-reactive MR1-restricted MAIT cells
Prabhat K. Sharma et al.
IMMUNOLOGY (2015)
Proteolytic degradation of neuropeptide Y (NPY) from head to toe: Identification of novel NPY-cleaving peptidases and potential drug interactions in CNS and Periphery.
Leona Wagner et al.
JOURNAL OF NEUROCHEMISTRY (2015)
The dipeptidyl peptidase family, prolyl oligopeptidase, and prolyl carboxypeptidase in the immune system and inflammatory disease, including atherosclerosis
Yannick Waumans et al.
FRONTIERS IN IMMUNOLOGY (2015)
Human Treg Cells Are Characterized by Low/Negative CD6 Expression
Carlos A. Garcia Santana et al.
CYTOMETRY PART A (2014)
Substance P Increases Sympathetic Activity During Combined Angiotensin-Converting Enzyme and Dipeptidyl Peptidase-4 Inhibition
Jessica K. Devin et al.
HYPERTENSION (2014)
Pancreatic Safety of Incretin-Based Drugs - FDA and EMA Assessment
Amy G. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Soluble DPP4 originates in part from bone marrow cells and not from the kidney
Zhendi Wang et al.
PEPTIDES (2014)
Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus Patients with Moderate to Severe Renal Impairment: A Systematic Review and Meta-Analysis
Dongsheng Cheng et al.
PLOS ONE (2014)
DPP4 inhibitor-induced polyarthritis: a report of three cases
Etienne Crickx et al.
RHEUMATOLOGY INTERNATIONAL (2014)
Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting insulin or placebo for patients with type 2 diabetes failing two oral antihyperglycaemic agents: a systematic review and network meta-analysis
Andrea C. Tricco et al.
BMJ OPEN (2014)
A Potential Role for Dendritic Cell/Macrophage-Expressing DPP4 in Obesity-Induced Visceral Inflammation
Jixin Zhong et al.
DIABETES (2013)
Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors
Alexandra E. Butler et al.
DIABETES (2013)
Polyarthropathy in type 2 diabetes patients treated with DPP4 inhibitors
Tatsuhiko Saito et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
CD26-mediated co-stimulation in human CD8+T cells provokes effector function via pro-inflammatory cytokine production
Ryo Hatano et al.
IMMUNOLOGY (2013)
Effects of dipeptidyl peptidase-4 inhibition in an animal model of experimental asthma: a matter of dose, route, and time
Michael Stephan et al.
PHYSIOLOGICAL REPORTS (2013)
Psoriasiform eruption triggered by a dipeptidyl peptidase IV inhibitor
Albert Mas-Vidal et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2012)
CD26: A negative selection marker for human Treg cells
Francisco J. Salgado et al.
CYTOMETRY PART A (2012)
Sitagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Psoriasis
Tatsuya Nishioka et al.
DERMATOLOGY (2012)
DPP-4 inhibitors in the management of type 2 diabetes: A critical review of head-to-head trials
A. J. Scheen
DIABETES & METABOLISM (2012)
Molecular mechanism and structural basis of interactions of dipeptidyl peptidase IV with adenosine deaminase and human immunodeficiency virus type-1 transcription transactivator
Hua Fan et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2012)
Enhanced ovalbumin-induced airway inflammation in CD26-/- mice
Shuling Yan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Development and resolution of colitis in mice with target deletion of dipeptidyl peptidase IV
Dijana Detel et al.
EXPERIMENTAL PHYSIOLOGY (2012)
Development of structural kidney damage in spontaneously hypertensive rats
Michael Hultstrom
JOURNAL OF HYPERTENSION (2012)
Human Th17 Cells Express High Levels of Enzymatically Active Dipeptidylpeptidase IV (CD26)
Bertram Bengsch et al.
JOURNAL OF IMMUNOLOGY (2012)
Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN- like proteases in cerebral ischemia
Peter Roehnert et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Serum levels of soluble CD26 and CD30 and their clinical significance in patients with rheumatoid arthritis
Hasan Ulusoy et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Serum and CSF soluble CD26 and CD30 concentrations in healthy pediatric surgical outpatients
W. Delezuch et al.
TISSUE ANTIGENS (2012)
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus
D. Pitocco et al.
ATHEROSCLEROSIS (2011)
Effector granules in human T lymphocytes: the luminal proteome of secretory lysosomes from human T cells
Hendrik Schmidt et al.
CELL COMMUNICATION AND SIGNALING (2011)
Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
Zubair Shah et al.
CIRCULATION (2011)
Dipeptidyl peptidase IV (DPP4) deficiency increases Th1-driven allergic contact dermatitis
T. Tasic et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2011)
Dipeptidyl Peptidase-4 Inhibition: Linking Chemical Properties to Clinical Safety
E. Matteucci et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase
Marjolein J. Willemen et al.
DIABETES CARE (2011)
Animal models of asthma: value, limitations and opportunities for alternative approaches
Anthony M. Holmes et al.
DRUG DISCOVERY TODAY (2011)
Pharmacology of Dipeptidyl Peptidase-4 Inhibitors Similarities and Differences
Roberta Baetta et al.
DRUGS (2011)
Fibroblast Activation Protein Expression in Crohn's Disease Strictures
Laura Rovedatti et al.
INFLAMMATORY BOWEL DISEASES (2011)
Neuroimmunomodulative Properties of Dipeptidyl Peptidase IV/CD26 in a TNBS-Induced Model of Colitis in Mice
Lara Baticic et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
The Safety of Incretin-Based Therapies-Review of the Scientific Evidence
Daniel J. Drucker et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Dipeptidyl peptidase-IV in synovial fluid and in synovial fluid mononuclear cells of patients with rheumatoid arthritis
Lucie Sromova et al.
CLINICA CHIMICA ACTA (2010)
Reduced airway inflammation in CD26/DPP4-deficient F344 rats is associated with altered recruitment patterns of regulatory T cells and expression of pulmonary surfactant proteins
A. Schmiedl et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2010)
Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13
D. RIEMANN et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Interactive Hemodynamic Effects of Dipeptidyl Peptidase-IV Inhibition and Angiotensin-Converting Enzyme Inhibition in Humans
Annis Marney et al.
HYPERTENSION (2010)
Dipeptidyl Peptidase IV Inhibition Alters the Hemodynamic Response to Angiotensin-Converting Enzyme Inhibition in Humans With the Metabolic Syndrome
Edwin K. Jackson
HYPERTENSION (2010)
Transferred T cells preferentially adhere in the BALT of CD26-deficient recipient lungs during asthma
Jutta Schade et al.
IMMUNOBIOLOGY (2010)
Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis
S. S. Engel et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
The dimeric transmembrane domain of prolyl dipeptidase DPP-IV contributes to its quaternary structure and enzymatic activities
Kuei-Min Chung et al.
PROTEIN SCIENCE (2010)
Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP
Rolf Mentlein
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Blockade of CD26-mediated T cell costimulation with soluble caveolin-1-Ig fusion protein induces anergy in CD4+T cells
Kei Ohnuma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses
Kalpit A. Vora et al.
BMC IMMUNOLOGY (2009)
On the origin of serum CD26 and its altered concentration in cancer patients
Oscar J. Cordero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Airway-specific recruitment of T cells is reduced in a CD26-deficient F344 rat substrain
J. Schade et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
CD26/dipeptidyl peptidase 4-deficiency alters thymic emigration patterns and leukcocyte subsets in F344-rats age-dependently
C. Klemann et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Phenotyping of congenic dipeptidyl peptidase 4 (DP4) deficient Dark Agouti (DA) rats suggests involvement of DP4 in neuro-, endocrine, and immune functions
Nadine Frerker et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Dipeptidyl Peptidase-4 (CD26): Knowing the Function before Inhibiting the Enzyme
E. Matteucci et al.
CURRENT MEDICINAL CHEMISTRY (2009)
CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL
Lilla Cro et al.
HEMATOLOGICAL ONCOLOGY (2009)
Differential expression of CD26 on virus-specific CD8+ T cells during active, latent and resolved infection
Chris C. Ibegbu et al.
IMMUNOLOGY (2009)
Natural killer cell cytotoxicity: how do they pull the trigger?
Nicola J. Topham et al.
IMMUNOLOGY (2009)
A CD26-Controlled Cell Surface Cascade for Regulation of T Cell Motility and Chemokine Signals
Zhiwen Liu et al.
JOURNAL OF IMMUNOLOGY (2009)
Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
Roger Yazbeck et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure
Edwin K. Jackson et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes
J. Rosenstock et al.
DIABETES OBESITY & METABOLISM (2008)
Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice
Roger Yazbeck et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis
Dirk Reinhold et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Inflammatory bowel diseases:: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors
Ute Bank et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Is dipeptidylpeptidase IV the missing link in angiotensin-converting enzyme inhibitor-induced angioedema?
Eric Grouzmann et al.
HYPERTENSION (2008)
Inhibition of CD26/dipeptidyl CCL11/eotaxin-mediated recruitment peptidase IV enhances of eosinophils in vivo
Ulf Forssmann et al.
JOURNAL OF IMMUNOLOGY (2008)
Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function
Kei Ohnuma et al.
TRENDS IN IMMUNOLOGY (2008)
Regulation of expression and function of dipeptidyl peptidase 4 (DP4), DP8/9, and DP10 in allergic responses of the lung in rats
Jutta Schade et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2008)
In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4+ T lymphocytes
T. Ellingsen et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
Increased expression of plasma and CD4+T lymphocyte costimulatory molecule CD26 in adult patients with allergic asthma
Samantha W. M. Lun et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2007)
Dose-dependent recruitment of CD25+ and CD26+ T cells in a novel F344 rat model of asthma
Thomas Skripuletz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
The Simpson-Golabi-Behmel syndrome causative Glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26
Jamshid Davoodi et al.
PROTEOMICS (2007)
Organelle proteomics
Tammy M. Casey et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
TGF-β1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26
Vera Preller et al.
JOURNAL OF IMMUNOLOGY (2007)
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
Kei Ohnuma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Does human attractin have DP4 activity?
Daniel Friedrich et al.
BIOLOGICAL CHEMISTRY (2007)
On the role of CD26 in CD4 memory T cells
Oscar J. Cordero et al.
IMMUNOBIOLOGY (2007)
Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation
Dirk Reinhold et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
CD4+memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis
M. Krakauer et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
DPP-4 inhibitors and their potential role in the management of type 2 diabetes
A. Barnett
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Thymic output in aged mice
J. Scott Hale et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Insulin-dependent phosphorylation of DPP IV in liver - Evidence for a role of compartmentalized c-Src
N Bilodeau et al.
FEBS JOURNAL (2006)
Trafficking on serpentines:: molecular insight on how maturating T cells find their winding paths in the thymus
A Misslitz et al.
IMMUNOLOGICAL REVIEWS (2006)
Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase IV
MS Geier et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Type 2 diabetes - Therapy with dipeptidyl peptidase IV inhibitors
HU Demuth et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Association of plasminogen with dipeptidyl peptidase IV and Na+/H+ exchanger isoform NHE3 regulates invasion of human 1-LN prostate tumor cells
M Gonzalez-Gronow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders
MD Gorrell
CLINICAL SCIENCE (2005)
Inhibition of dipeptidyl peptidase-4 augments insulin secretion in response to exogenously administered glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, pituitary adenylate cyclase-activating polypeptide, and gastrin-releasing peptide in mice
B Ahrén et al.
ENDOCRINOLOGY (2005)
Circulating CD26 is negatively associated with inflammation in human and experimental arthritis
N Busso et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
CD26 (dipeptidyl-peptidase IV)-dependent recruitment of T cells in a rat asthma model
C Kruschinski et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation
K Aertgeerts et al.
PROTEIN SCIENCE (2004)
Enrichment for a CD26hi SIRP- subset in lymph dendritic cells from the upper aero-digestive tract
M Epardaud et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Role of dipeptidyl peptidase IV in regulating activity of Na+/H+ exchanger isoform NHE3 in proximal tubule cells
ACC Girardi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Crystal structure of CD26/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface
WA Weihofen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cell surface adenosine deaminase binds and stimulates plasminogen activation on 1-LN human prostate cancer cells
M Gonzalez-Gronow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
NPY, NPY receptors, and DPP IV activity are modulated by LPS, TNF-α and IFN-γ in HUVEC
AP Silva et al.
REGULATORY PEPTIDES (2003)
Extreme reduction of dipeptidyl peptidase IV activity in F344 rat substrains is associated with various behavioral differences
T Karl et al.
PHYSIOLOGY & BEHAVIOR (2003)
1-benzyl-2-acetamido-2-deoxy-α-D-galactopyranoside blocks the apical biosynthetic pathway in polarized HT-29 cells
D Delacour et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Localization, transmission, spontaneous mutations, and variation of function of the Dpp4 (Dipeptidyl-peptidase IV; CD26) gene in rats
T Karl et al.
REGULATORY PEPTIDES (2003)
CD26 expression determines lung metastasis in mutant F344 rats:: involvement of NK cell function and soluble CD26
K Shingu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis
HC Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Behavioral effects of neuropeptide Y in F344 rat substrains with a reduced dipeptidyl-peptidase IV activity
T Karl et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2003)
Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen
SL Yan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
The crystal structure of dipeptidyl peptidase IV(CD26) reveals its functional regulation and enzymatic mechanism
M Engel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The multifunctional or moonlighting protein CD26/DPPIV
E Boonacker et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2003)
Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog
HB Rasmussen et al.
NATURE STRUCTURAL BIOLOGY (2003)
Asthma: an epidemic of dysregulated immunity
DT Umetsu et al.
NATURE IMMUNOLOGY (2002)
The tachykinin peptide family
C Severini et al.
PHARMACOLOGICAL REVIEWS (2002)
Soluble CD26/dipeptidyl peptidase IV enhances transendothelial migration via its interaction with mannose 6-phosphate/insulin-like growth factor II receptor
H Ikushima et al.
CELLULAR IMMUNOLOGY (2002)
Expression of dipeptidyl-peptidase IV (CD26) on CD8+ T cells is significantly decreased in patients with psoriasis vulgaris and atopic dermatitis
O Bock et al.
EXPERIMENTAL DERMATOLOGY (2001)
CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO
T Ishii et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease
M Hildebrandt et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2001)
CD26: A multifunctional integral membrane and secreted protein of activated lymphocytes
MD Gorrell et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2001)
Differential effects of neuropeptide Y (NPY) on leukocyte subsets in the blood:: mobilization of B-1-like B-lymphocytes and activated monocytes
S Bedoui et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Comodulation of CXCR4 and CD26 in human lymphocytes
C Herrera et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-β1 secretion in vivo
A Steinbrecher et al.
JOURNAL OF IMMUNOLOGY (2001)
Reference values for plasma dipeptidyl-peptidase IV activity and iheir association with other laboratory parameters
C Durinx et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2001)
Molecular characterization of dipeptidyl peptidase activity in serum -: Soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides
C Durinx et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation
H Ikushima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cells
B Bauvois et al.
ONCOGENE (2000)
分享论文
